A sign of what's com­ing? Pres­i­den­tial hope­ful De­San­tis tar­gets PBMs and phar­ma trans­paren­cy

3 years ago
People
Law

Mer­ck, Vi­a­tris agree to set­tle patent feud sur­round­ing di­a­betes drugs

3 years ago
Pharma
Law

Ab­b­Vie cel­e­brates decade of phar­ma work in newest cor­po­rate cam­paign

3 years ago
Pharma
Marketing

Most dos­es of No­vo Nordisk's Ozem­pic are re­moved from FDA drug short­age list af­ter sup­ply is­sues

3 years ago
Pharma
Manufacturing

Cal­i­for­nia takes an­oth­er step for­ward in its in­sulin pro­duc­tion with $50M in­vest­ment

3 years ago
Pharma
Manufacturing

FDA in­di­cates will­ing­ness to ap­prove Bio­gen ALS drug de­spite failed PhI­II study

3 years ago
R&D
FDA+

BioN­Tech to pay $200M up­front in CT­LA-4 an­ti­body de­vel­op­ment, com­mer­cial­iza­tion deal

3 years ago
Deals

Athenex dis­clos­es pa­tient death, clin­i­cal hold on CAR-NKT tri­al as it seeks strate­gic al­ter­na­tives

3 years ago
R&D
Cell/Gene Tx

Gilead taps Nurix pro­tein de­grad­er op­tion for $20M

3 years ago
Deals

Sy­neos Health inks deal with Mi­crosoft to use AI tech­nol­o­gy

3 years ago
Deals
AI

'No find­ing of re­search mis­con­duc­t': MIT ends 3.5-year re­view of biotech founder, pro­fes­sor Sasisekha­ran

3 years ago
People

Dai­ichi and Zymeworks end an­ti­body pact af­ter sev­en years

3 years ago
Deals

No­var­tis and Bio­gen pull out of neu­ro drug part­ner­ships with Sang­amo

3 years ago
Deals
Cell/Gene Tx

Karuna’s schiz­o­phre­nia drug clears an­oth­er PhI­II as biotech seeks 2024 launch

3 years ago
R&D

What kind of PhI­Ib da­ta is worth $4B cash? Take­da’s Andy Plump has some thoughts on that

3 years ago
Deals
R&D

Seagen goes to Pfiz­er for $43B; Sanofi buys di­a­betes part­ner Proven­tion; Cri­sis avert­ed in SVB demise; and more

3 years ago
Weekly

J&J fi­nal­izes $25M set­tle­ment, lay­ing Rem­i­cade an­titrust al­le­ga­tions to rest

3 years ago
Pharma
Law

Ve­rastem's new cam­paign aims to make dis­tinc­tions in rare type of ovar­i­an can­cer

3 years ago
Pharma
Marketing

GAO on com­bo prod­uct patents: Stake­hold­ers split on need for Or­ange Book tweaks

3 years ago
FDA+

Sam­sung Bi­o­log­ics to kick off $1.5B+ plant con­struc­tion in South Ko­rea

3 years ago
Manufacturing

No­var­tis' Tafin­lar/Mekin­ist com­bo scores new in­di­ca­tion in pe­di­atric brain can­cer

3 years ago
Pharma
FDA+

Ipsen re­ceives new palo­varotene PDU­FA date; Ac­er halts de­vel­op­ment of ex-Sanofi drug

3 years ago
News Briefing

Pfiz­er's Bourla and Mod­er­na's Ban­cel saw com­pen­sa­tion bumps in 2022

3 years ago
People
Pharma

Gos­samer stops en­roll­ment on BTK in­hibitor pro­gram, goes all in on PAH drug

3 years ago
R&D
First page Previous page 359360361362363364365 Next page Last page
A service from the Financial Times